SECURE CLOUD ACCESS

IF THERE IS NO EARLY DIAGNOSIS,
THEN THERE IS NO TIMELY TREATMEN

AUTONOMIC NERVOUS SYSTEM
​AND VASCULAR ASSESSMENTS

ANS-1 SYSTEM

ANS-1 system integrates 3 technologies based on Galvanic skin response ,  photoplethysmography analysis and oscillometry to assess the Autonomic Nervous System and Peripheral circulation.

 ​AUTONOMIC NERVOUS SYSTEM ASSESSMENT

TECHNOLOGIES :
GALVANIC SKIN RESPONSE+ OSCILLOMETRY + PHOTOPLETHYSMOGRAPHY

      
ANS-1 System manages the Autonomic Nervous System battery of tests recommended by the American Academy of Neurology since 1996, and the Cardiovascular Autonomic Neuropathy Subcommittee of the Toronto Consensus Panel on Diabetic Neuropathy, for assessing the Autonomic Nervous System.

Autonomic testing is recommended for all patients with type 2 diabetes at the time of the diagnosis, and 5 years after diagnosis in individuals with type 1 diabetes.
( Boulton et al., 2005;Tesfaye et al., 2010;Spallone et al., 2011; Bernardi et al.,2011.)

Patient setup ANS-1, instruction for use
ANS-1 BENEFITS
Benefit of ANS-1, no human error
Benefit of ANS-1, clear report
Benefit of ANS-1, accurate result
Benefit of ANS-1, simultaneous measurement, 7-10 minutes
Benefit of ANS-1, ANS and Artery overview
ANS-1 MARKERS

Vascular function Assessment 
Arterial stiffness
​Brachial blood pressure

Homeostatic Markers  :
​Off label use: Patented markers from  mathematical analysis of the photoplethysmography
ANS Assessment :
Sudomotor markers 
​Heart rate variability Analysis and
Cardiac Autonomic Reflex Tests ( Valsalva Ratio, E/I Ratio, K30/15 Ratio and Systolic response difference while standing).​​

                ANS-1 FEATURES
sudomotor dysfunction
cardiac autonomic neuropathy
microcirculation disorders
ANS-1 REVIEW BY DR. JIMMY NINH
Download LD  Products Catalog